Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Urologic Neoplasms 2Stomach Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Obesity 1Neuromuscular Blockade 1Myasthenia Gravis 1Endobronchial Metastases 1Delayed Emergence from Anesthesia 1Brain Neoplasms 1

Interventions

Metformin 14Exercise 14Resistance Training 5Nutrition Assessment 5Methods 5Exenatide 5Diet 5Diet Therapy 4Surveys and Questionnaires 3Sugars 3Early Intervention, Educational 3Counseling 3Caloric Restriction 3exemestane 2Yoga 2Vitamin D 2Nutritional Status 2Naltrexone 2Mindfulness-Based Stress Reduction 2Liraglutide 2Educational Status 2Docosahexaenoic Acids 2Diet, Mediterranean 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2sibutramine 1rosiglitazone-metformin combination 1penclomedine 1licogliflozin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Obesity × Sugammadex × Clear all
NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Korea University Anam Hospital

Phase 3 Completed
196 enrolled 11 charts
GastrointestinalOther

Obesity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡